Literature DB >> 22388174

Intracellularly transported adenosine induces apoptosis in [corrected] MCF-7 human breast cancer cells by accumulating AMID in the nucleus.

Ayako Tsuchiya1, Takeshi Kanno, Masaru Saito, Yasuo Miyoshi, Akinobu Gotoh, Takashi Nakano, Tomoyuki Nishizaki.   

Abstract

Extracellular adenosine induced apoptosis of MCF-7 human breast cancer cells in a concentration (10μM-10mM)- and treatment time (24-72h)-dependent manner, and the effect was inhibited by the adenosine transporter inhibitor dipyridamole, but not an inhibitor of adenosine kinase, an inhibitor of AMP-activated protein kinase, or inhibitors for A(1), A(2a), A(2b), and A(3) adenosine receptors. No significant activation of caspase-7, -8, or -9 was obtained with adenosine. Adenosine promoted translocation of apoptosis-inducing factor (AIF)-homologous mitochondrion-associated inducer of death (AMID) from the cytosol into the nucleus, although the total amount of AMID was not affected. Adenosine-induced MCF-7 cell death was abrogated by knocking-down AMID. The results of the present study indicate that intracellularly transported adenosine induces MCF-7 cell apoptosis by accumulating AMID in the nucleus in a caspase-independent manner.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22388174     DOI: 10.1016/j.canlet.2012.02.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

Review 1.  Anticancer effect of adenosine on gastric cancer via diverse signaling pathways.

Authors:  Ayako Tsuchiya; Tomoyuki Nishizaki
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.

Authors:  Fabrícia Dietrich; Fabrício Figueiró; Eduardo Cremonese Filippi-Chiela; Angélica Regina Cappellari; Liliana Rockenbach; Alain Tremblay; Patrícia Boni de Paula; Rafael Roesler; Aroldo Braga Filho; Jean Sévigny; Fernanda Bueno Morrone; Ana Maria Oliveira Battastini
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-05       Impact factor: 4.553

Review 3.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

Review 4.  Immunity, inflammation and cancer: a leading role for adenosine.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Nat Rev Cancer       Date:  2013-11-14       Impact factor: 60.716

Review 5.  Adenosine kinase: An epigenetic modulator in development and disease.

Authors:  Madhuvika Murugan; Denise Fedele; David Millner; Enmar Alharfoush; Geetasravya Vegunta; Detlev Boison
Journal:  Neurochem Int       Date:  2021-05-05       Impact factor: 4.297

6.  Dynamic Regulation of the Adenosine Kinase Gene during Early Postnatal Brain Development and Maturation.

Authors:  Katharina Kiese; Janos Jablonski; Detlev Boison; Katja Kobow
Journal:  Front Mol Neurosci       Date:  2016-10-20       Impact factor: 5.639

7.  Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.

Authors:  Xiwei Yu; Jiahui Hou; Yijie Shi; Chang Su; Liang Zhao
Journal:  Int J Nanomedicine       Date:  2016-11-14

8.  ATF6 aggravates acinar cell apoptosis and injury by regulating p53/AIFM2 transcription in Severe Acute Pancreatitis.

Authors:  Jie-Hui Tan; Rong-Chang Cao; Lei Zhou; Zhi-Tao Zhou; Huo-Ji Chen; Jia Xu; Xue-Mei Chen; Yang-Chen Jin; Jia-Yu Lin; Jun-Ling Zeng; Shu-Ji Li; Min Luo; Guo-Dong Hu; Xiao-Bing Yang; Jin Jin; Guo-Wei Zhang
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

9.  Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells.

Authors:  Paola de Andrade Mello; Eduardo Cremonese Filippi-Chiela; Jéssica Nascimento; Aline Beckenkamp; Danielle Bertodo Santana; Franciele Kipper; Emerson André Casali; Alessandra Nejar Bruno; Juliano Domiraci Paccez; Luiz Fernando Zerbini; Marcia Rosângela Wink; Guido Lenz; Andréia Buffon
Journal:  Mol Biol Cell       Date:  2014-08-07       Impact factor: 4.138

10.  Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.

Authors:  Barbara Kutryb-Zajac; Patrycja Koszalka; Paulina Mierzejewska; Alicja Bulinska; Magdalena A Zabielska; Karolina Brodzik; Aleksandra Skrzypkowska; Lukasz Zelazek; Iwona Pelikant-Malecka; Ewa M Slominska; Ryszard T Smolenski
Journal:  J Cell Mol Med       Date:  2018-10-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.